Astec Lifesciences consolidated net profit rises 79.67% in the March 2022 quarter

2 May 2022 , 06:11 PM

Net profit of Astec Lifesciences rose 79.67% to Rs 43.05 crore in the quarter ended March 2022 as against Rs 23.96 crore during the previous quarter ended March 2021. Sales rose 58.20% to Rs 271.98 crore in the quarter ended March 2022 as against Rs 171.92 crore during the previous quarter ended March 2021.

For the full year,net profit rose 38.14% to Rs 89.86 crore in the year ended March 2022 as against Rs 65.05 crore during the previous year ended March 2021. Sales rose 21.93% to Rs 676.57 crore in the year ended March 2022 as against Rs 554.87 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	271.98	171.92	58	676.57	554.87	22
OPM %	24.07	22.21	–	22.77	20.11	–
PBDT	68.94	38.70	78	155.48	114.73	36
PBT	58.30	32.18	81	121.13	89.07	36
NP	43.05	23.96	80	89.86	65.05	38

Powered by Capital Market – Live News